Werewolf Therapeutics Stock Target Price and Analyst Consensus
| HOWL Stock | USD 4.96 0.08 1.64% |
The current analyst and expert consensus on Werewolf Therapeutics is Strong Buy, with 4 strong buy opinions. The current projected Werewolf Therapeutics target price consensus is 12.20 with 6 analyst opinions. The most common way Werewolf Therapeutics analysts use to provide recommendation to the public is financial statements analysis. Many experts also interview Werewolf Therapeutics executives and customers to further validate their buy or sell advice. Note, the total number of analysts currently providing their opinion is not significant to determine adequate consensus on Werewolf Therapeutics. We strongly encourage you to use your own analysis of Werewolf Therapeutics to validate this buy or sell advice. Werewolf Therapeutics buy-or-sell recommendation module provides average expert sentiment on the projected Werewolf Therapeutics target price to derive its highest and lowest estimates based on its projected price volatility. Check out Macroaxis Advice on Werewolf Therapeutics to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. For more information on how to buy Werewolf Stock please use our How to buy in Werewolf Stock guide.
Lowest Forecast 11.1 | Highest Forecast 13.54 | Target Price 12.2 |
Werewolf |
It's important to approach Werewolf Therapeutics' target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.
Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.
Steps to utilize Werewolf Therapeutics price targets
Werewolf Therapeutics' stock target price is an estimate of its future price, usually made by analysts. Using Werewolf Therapeutics' target price to determine if it is a suitable investment can be done through the following steps:- Look at Werewolf Therapeutics' target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
- Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
- Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
- Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if Werewolf Therapeutics' stock is likely to perform well.
- Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Additional Werewolf Therapeutics Value Projection Modules
Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Werewolf Therapeutics is a key component of Werewolf Therapeutics valuation and have some predictive power on the future returns of a Werewolf Therapeutics.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Werewolf Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment. | Chemicals Invested over 30 shares | |
 | Automobiles and Trucks Invested over 60 shares | |
 | Investor Favorites Invested over 70 shares | |
 | FinTech Invested over 40 shares | |
 | Macroaxis Index Invested few shares | |
 | Momentum Invested few shares | |
 | SRI Sustainable Growth Invested few shares | |
Check out Macroaxis Advice on Werewolf Therapeutics to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. For more information on how to buy Werewolf Stock please use our How to buy in Werewolf Stock guide.You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Complementary Tools for Werewolf Stock analysis
When running Werewolf Therapeutics' price analysis, check to measure Werewolf Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Werewolf Therapeutics is operating at the current time. Most of Werewolf Therapeutics' value examination focuses on studying past and present price action to predict the probability of Werewolf Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Werewolf Therapeutics' price. Additionally, you may evaluate how the addition of Werewolf Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Global Correlations Find global opportunities by holding instruments from different markets |
The data published in Werewolf Therapeutics' official financial statements usually reflect Werewolf Therapeutics' business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Werewolf Therapeutics. For example, before you start analyzing numbers published by Werewolf accountants, it's critical to develop an understanding of what Werewolf Therapeutics' liquidity, profitability, and earnings quality are in the context of the Biotechnology space in which it operates.
Please note, the presentation of Werewolf Therapeutics' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Werewolf Therapeutics' management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Werewolf Therapeutics' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Werewolf Therapeutics. Please utilize our Beneish M Score to check the likelihood of Werewolf Therapeutics' management manipulating its earnings.